Sanofi to open technology hub in Barcelona with 300 jobs
The pharmaceutical company assures that it is making an "increasingly important" commitment to the Catalan capital.
BarcelonaThe biopharmaceutical multinational Sanofi announced this Tuesday the creation of a hub innovation center in Barcelona, in the 22@ technology district, with 300 "high-talent" jobs and which will be fully operational by the end of this year. This was announced by the general manager of Sanofi Iberia, Raquel Tapia, during the inauguration of the Science Lab, a traveling interactive exhibition that brings science, immunology and innovation closer to the public and which can be seen until April 26 at the Moll de la Barceloneta.
"We are bringing 300 highly qualified jobs to the city of Barcelona, which will be working in digital innovation along with R&D in healthcare to provide the best for patients," indicated Tapia. The future workers of the hub The multinational, which has a corporate headquarters in the Catalan capital and a production plant in Riells and Viabrea (Selva), will address issues as "important" as data science, artificial intelligence (AI) engineering, and biostatistics. hub has received support from Acción.
The new center will promote high-impact initiatives to improve the health and quality of life of patients worldwide. The company intends to work on the generation of real-world evidence (RWE), with the support of expert teams in biostatistics, statistical programming, and clinical data analysis, as well as in data engineering and science to perform advanced analytics that enable more informed decisions across the organization. It will also support Sanofi's medical and scientific teams, as well as its R&D and supply chain departments, and will strengthen its role as a driver of innovation and operational excellence across the company.
Investing in Barcelona
In fact, during the inauguration of the Science Lab, Tapia stated that the commitment to Barcelona represents another step towards making the Catalan and Spanish capital an "increasingly important" space for Sanofi's operations. In this sense, the new hub The Barcelona-based company will be part of the company's global network of strategic centers, including those in Hyderabad (India), Kuala Lumpur (Malaysia), Budapest (Hungary), and Bogotá (Colombia). Tapia also emphasized the importance of a "predictable and stable" regulatory framework in the pharmaceutical sector in order to carry out investments of this nature.